DEBBIE ANDERSON: Open Payments
NPI 1528417631 · DESLOGE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,442 in 148 payments from 37 companies in 2025. Trend: 2023 $2,827 · 2024 $2,927 · 2025 $2,442
Food & beverage: $2,405Education: $38
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $454 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $205 |
| PFIZER INC. | 13 | $165 |
| Axsome Therapeutics, Inc. | 2 | $163 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $110 |
| Aimmune Therapeutics, Inc. | 6 | $109 |
| Vanda Pharmaceuticals Inc. | 6 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Teva Pharmaceuticals USA, Inc. | 6 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
Products named: QULIPTA, CAPLYTA, Auvelity, REXULTI, VRAYLAR, ZENPEP, ELIQUIS, FANAPT.
Industry payments across MO — which companies pay providers there.
